Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

11.01USD
8 Dec 2016
Change (% chg)

$-0.03 (-0.27%)
Prev Close
$11.04
Open
$10.99
Day's High
$11.03
Day's Low
$10.50
Volume
101,050
Avg. Vol
98,759
52-wk High
$37.61
52-wk Low
$9.24

NLNK.OQ

Chart for NLNK.OQ

About

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $321.65
Shares Outstanding(Mil.): 29.13
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 41.20 30.65
EPS (TTM): -3.23 -- --
ROI: -51.60 -0.59 15.23
ROE: -53.93 -1.31 16.56

BRIEF-NewLink Genetics Q3 loss $0.54/shr

* NewLink Genetics Corp says expects to have approximately $132 million in cash and equivalents on December 31, 2016

Nov 01 2016

BRIEF-Newlink Genetics awarded $25 mln contract from BARDA for investigational Ebola Zaire vaccine (V920)

* Newlink Genetics awarded $25 million contract from BARDA for investigational Ebola Zaire vaccine (V920) Source text for Eikon: Further company coverage:

Oct 04 2016

BRIEF-Newlink Genetics Q2 loss per share $1.12

* Implemented a significant restructuring program following may results of impress phase 3 study of algenpantucel-l

Jul 29 2016

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,526 --
Pfizer Inc. (PFE.N) $30.94 -0.25
Novartis AG (NOVN.S) CHF68.50 -0.25
Merck & Co., Inc. (MRK.N) $60.12 +0.06
Roche Holding Ltd. (ROG.S) CHF220.40 -0.80
Roche Holding Ltd. (RO.S) CHF226.10 +0.90
Abbott Laboratories (ABT.N) $38.68 +0.20
Sanofi SA (SASY.PA) €75.08 -0.02
AstraZeneca plc (AZN.L) 4,116.00p +109.00
GlaxoSmithKline plc (GSK.L) 1,460.00p -2.50

Earnings vs. Estimates